National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

Statutory Rules

1978 No. 142

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1933*

WHEREAS it is provided by sub-section 101 (4) of the National Health Act 1953 that a drug or medicinal preparation that was not a pharmaceutical benefit under that Act immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee, has recommended to the Minister that it be so prescribed:

AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953, namely the drugs and medicinal preparations specified in Schedule 3 to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:

NOW THEREFORE I, THE GOVERNOR-GENERAL of the Commonwealth, of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.

Dated this twenty-first day of July 1978.

ZELMAN COWEN

Governor-General

By His Excellency’s Command,

  

RALPH J. HUNT

Minister of State for Health

____________________________________________________________________________

* Notified in the Commonwealth of Australia Gazette on 27 July 1978.

13008/78 Cat. No. —Recommended retail price 15c 12/3.7.1978

AMENDMENTS OF THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS*

Commencement

1. These Regulations shall come into operation on 1 August 1978.

Schedule 1

2. Schedule 1 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 1.

Schedule 2

3. Schedule 2 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 2.

Schedule 3

4. Schedule 3 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 3.

Schedule 4

5. Schedule 4 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 4.

Schedule 5

6. Schedule 5 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 5.

_____________

SCHEDULE 1 Regulation 2

AMENDMENTS OF SCHEDULE 1 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

1. After item 38, insert the following items:

“ 38a Beclomethasone Cream

“ 38b Beclomethasone Ointment ”.

2. After item 48, insert the following item:

“ 48a Boric Acid ”.

3. After item 459, insert the following items:

“ 459a Phenformin Hydrochloride

“ 459b Phenformin Tablets ”.

_____________

SCHEDULE 2 Regulation 3

AMENDMENTS OF SCHEDULE 2 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

1. After item 13, insert the following item:
“ 13a ‘AMINOFUSIN L 10%’	—”.
2. After item 54, insert the following item:
“ 54a Clotrimazole ..........	—”.
3. Omit item 94.
4. Omit item 105, substitute the following item:
“ 105 Gramicidin..............	Framycetin Sulphate with Dexamethasone and Gramicidin
Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin
Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin
Polymyxin. B Sulphate with Neomycin Sulphate and Gramicidin ”.

_________________________________________________________________________________

* Statutory Rules 1960, No. 17 as amended to date. For previous amendments see footnote * to Statutory Rules 1978, No. 47 and see also Statutory Rules 1978, No. 47.

SCHEDULE 2—continued

5. Omit item 110, substitute the following item:
“ 110 Hydrocortisone Acetate ..	Neomycin Sulphide with Hydrocortisone Acetate
Oxytetracycline Hydrochloride and Hydrocortisone Acetate ”.
6. Omit item 119, substitute the following item:
“ 119 Levodopa, B.P........................	Benserazide with Levodopa, B.P.
Carbidopa with Levodopa, B.P.”.
7. Omit item 139, substitute the following item:
“ 139 Neomycin Sulphate ................	Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate
Colistin Sulphate with Neomycin Sulphate
Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate
Hydrocortisone Acetate with Neomycin Sulphate
Hydrocortisone with Neomycin Sulphate
Natamycin with Hydrocortisone and Neomycin Sulphate
Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate
Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate
Polymyxin B Sulphate with Hydrocortisone, and Neomycin Sulphate ”.
8. Omit item 172, substitute the following item:
“ 172 Polymyxin B Sulphate ............	Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate
Chloramphenicol with Polymyxin B Sulphate
Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate
Oxytetracycline Hydrochloride with Polymyxin B Sulphate
Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate
Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin
.	Propylene Glycol with Acetic Acid; and Polymyxin B Sulphate ”.
9. Omit item 213
10. Omit item 214.

___________

SCHEDULE 3 Regulation 4

AMENDMENTS OF SCHEDULE 3 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

1. After item 24, insert the following item:

“ 24a ‘ AMINOFUSIN L 10% ’.

2. After item 41, insert the following item:

“ 41a Benserazide ”.

3. After item 77, insert the following item:

“ 77a Cimetidine ”.

4. After item 80, insert the following item:

“ 86a Clotrimazole ”.

5. After item 113, insert the following items:

“ 113a Disopyramide

“ 113b Disopyramide Phosphate ”.

6. Omit item 133.

7. Omit item 335.

8. Omit item 336.

9. After item 337, insert the following item:

“ 337a Timolol Maleate ”.

SCHEDULE 4 Regulation 5

AMENDMENTS OF SCHEDULE 4 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

After item 3, insert the following item:

“ 3a Boric Acid B.P.”.

SCHEDULE 5 Regulation 6

AMENDMENTS OF SCHEDULE 5 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

1. After item 38, insert the following item:

“ 38a Cimetidine .. ..................

With the written authority of the Director-General—

Duodenal ulcer, proven by radiology or endoscopy

Gastric ulcer, proven by radiology or endoscopy

Zollinger-Ellison syndrome, proven by investigation ”.

2. After item 41, insert the following item:

“ 41a Clotrimazole Cream........

Cutaneous candidiasis

Dermatomycosis

Pityriasis versicolor ”.

3. After item 59, insert the following item:

“ 59a (1) Disopyramide............

With the written authority of the Director-General, cardiac arrhythmias, only when other anti-arrhythmic drug therapy is unsatisfactory ”.

(2) Disopyramide Phosphate

4. Omit item 88, substitute the following item:

“ 88

 (1) Levodopa, B.P. with  

 Benserazide..........

Treatment of Parkinson’s Disease ”.

(2) Levodopa, B.P. with Carbidopa

(3) Levodopa Capsules, B.P.

(4) Levodopa Tablets, B.P.

5. Omit item 96, substitute the following item:

“ 96 Maphenide Acetate

With the written authority of the Director-General-, treatment, in a hospital, of burns ”.

6. After item 111, insert the following item:

“ 111aa Metoclopramide Hydrochloride 10 mg Tablets........

For use in a hospital for chronic gastric retention after gastric surgery ”.

7. Omit item 133.

8. Omit item 142, substitute the following item:

“ 142 Prazosin Hydrochloride ..

Refractory hypertension ”.

9. After item 170, insert the following item:

“ 170a Timolol Malcate ...........

Dissecting aneurysm (aortic)

Frequent disabling angina without evidence of cardiac failure

Hypertension

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

Thyrotoxicosis ”.

      

Printed by Authority by the Commonwealth Government Printer